Tickerplace logo

Tickerplace

Kymera Therapeutics, Inc. logo

KYMRKymera Therapeutics, Inc.

KYMR Stock Price, Valuation & Chart | Kymera Therapeutics, Inc.

Compare
$104.78-3.36 (-3.11%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

KYMR Historical price chart

KYMR Key Stats

Market Capitalization8.62B
PE Ratio-32.74
EPS-3.2
Trading Volume488.72K
Today's High/Low108.63/104.39
Dividend Yield0.00
52 Week High/Low130.05/55.26
Shares Outstanding82.26M
KYMR Financial Statement
KYMR Analyst ratings
KYMR Analysis & performance metrics

KYMR Company profile

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing…

KYMR Management team

Management
Bruce L. Booth DPHIL, Ph.D.
Co-Founder & Independent Chairman
Noah Goodman M.B.A.
Chief Business Officer
Juliet Williams B.A Ph.D.
Head of Research
Nello Mainolfi M.D., Ph.D.CEO
Co-Founder, President, Chief Executive Officer & Director
Jeremy G. Chadwick Ph.D.COO
Chief Operating Officer
Ellen V. Chiniara Esq., J.D.
Chief Legal Officer & Corporate Secretary
Jared A. Gollob M.D.
Chief Medical Officer
Justine E. Koenigsberg
Vice President of Investor Relations
Total 8 executives

KYMR Frequently asked questions

What is Kymera Therapeutics, Inc. (KYMR) Stock Price?

Current stock price of Kymera Therapeutics, Inc. (KYMR) stock is $104.78. The stock price is -3.11% lower in the session. The intraday range can be seen from this page. Volume of Kymera Therapeutics, Inc. (KYMR) stock is 488.72K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Kymera Therapeutics, Inc. (KYMR) stock price going up or down today?

The stock price of Kymera Therapeutics, Inc. (KYMR) can change with earnings, company news, and overall market sentiment. Kymera Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Kymera Therapeutics, Inc. stock expensive at its current price?

Whether Kymera Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KYMR on this page is -32.74. EPS on this page is -3.20. Compare those figures with peers and growth expectations before deciding if the current Kymera Therapeutics, Inc. price is justified.

How has the stock price of Kymera Therapeutics, Inc. (KYMR) performed historically?

Historical performance for Kymera Therapeutics, Inc. (KYMR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KYMR reacted to past earnings and market events.

Should I buy Kymera Therapeutics, Inc. (KYMR) stock, at this price?

Buying Kymera Therapeutics, Inc. (KYMR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.